ClinicalTrials.gg
Drug

Trifarotene clinical trials

studies test it
14
open now
0
in phase 3
6
first study started
2012

How each study uses trifarotene is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
4 Oct 2019 · AKLIEF · NDA 211527 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Trifarotene Cream
3
AKLIEF®
3
Trifarotene
2
Trifarotene Cream 0.005%
2
Test Product
2

Development codes

CD5789
1

Studies by the year they started

14 studies that test it; most in 2015 (3)

Studies that test trifarotene, by start year
YearStudies
20121
20131
20153
20192
20201
20212
20221
20231
20241
20251

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
2
Phase 3
6
Phase 4
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 13 · Other 1

Galderma R&D (9) · Taro Pharmaceuticals USA (2) · Teva Pharmaceuticals USA (1) · M.D. Anderson Cancer Center (1) · Mayne Pharma International Pty Ltd (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test trifarotene, phase 3 first.

Studies

Open first, then newest update. How each study uses trifarotene is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 14

Codes

What other systems call trifarotene · ClinicalTrials.gg INT001022

  • MeSH (NLM) C000629420trifaroteneConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 0J8RN2W0HKTRIFAROTENEConfirmed FDA, NLM, Wikidata
  • RxNorm 2205637Confirmed FDA, Wikidata
  • Wikidata Q27236856trifaroteneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C118577TrifaroteneOne source FDA
  • DrugBank DB12808One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.